Loading insider details...
Beta
Latest Form 4 (Sep 18, 2026): Grant/Award of 25,370 IMUX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 18, 2026 | IMMUNIC, INC. (IMUX) | Grant/Award | 25,370 | n/a |
| Jul 16, 2026 | XOMA Royalty Corp (XOMA) | Tender of Shares | 3,635,758 | n/a |
| Jun 26, 2026 | Kymera Therapeutics, Inc. (KYMR) | Sale | 837,914 | $89.24M |
| Jun 25, 2026 | Kymera Therapeutics, Inc. (KYMR) | Grant/Award | 6,068 | n/a |
| Jun 23, 2026 | Olema Pharmaceuticals, Inc. (OLMA) | Grant/Award | 29,500 | n/a |
| Jun 22, 2026 | MoonLake Immunotherapeutics (MLTX) | Grant/Award | 22,195 | n/a |
| May 18, 2026 | XOMA Royalty Corp (XOMA) | Conversion | 2,313,000 | $9.32M |
| Apr 2, 2026 | MoonLake Immunotherapeutics (MLTX) | Sale | 1,932,354 | $32.44M |
| Oct 14, 2025 | ESSA Pharma Inc. (EPIX) | Tender of Shares | 6,194,145 | n/a |
| Aug 7, 2025 | ESSA Pharma Inc. (EPIX) | In-the-Money Exercise | 1,481,634 | $148.16 |